CytomX Income Statement Research

CTMX Stock  USD 2.19  0.08  3.79%   
Most accounts from CytomX Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CytomX Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out CytomX Therapeutics Valuation and CytomX Therapeutics Correlation analysis.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
  
At this time, CytomX Therapeutics' Other Operating Expenses is fairly stable compared to the past year. Research Development is likely to rise to about 86.4 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 2 M in 2024.
Most accounts from CytomX Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CytomX Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out CytomX Therapeutics Valuation and CytomX Therapeutics Correlation analysis.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.At this time, CytomX Therapeutics' Other Operating Expenses is fairly stable compared to the past year. Research Development is likely to rise to about 86.4 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 2 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit69.6M53.2M99.0M53.9M
Total Revenue69.6M53.2M101.2M54.2M

CytomX Therapeutics income statement Correlations

0.480.980.850.860.97-0.67-0.670.96-0.66-0.210.96-0.610.49-0.59-0.17-0.53-0.120.530.490.010.88-0.220.24
0.480.40.250.250.46-0.49-0.50.48-0.49-0.20.46-0.440.59-0.43-0.1-0.4-0.120.590.580.490.49-0.080.09
0.980.40.850.860.99-0.71-0.720.97-0.7-0.220.99-0.650.44-0.64-0.07-0.610.00.550.510.050.84-0.190.2
0.850.250.851.00.85-0.34-0.350.85-0.33-0.160.85-0.270.53-0.25-0.14-0.19-0.130.590.58-0.060.74-0.310.47
0.860.250.861.00.86-0.35-0.360.85-0.34-0.150.86-0.280.52-0.26-0.14-0.2-0.130.590.58-0.060.75-0.30.45
0.970.460.990.850.86-0.74-0.741.0-0.73-0.171.0-0.670.45-0.66-0.07-0.61-0.010.580.550.160.83-0.160.15
-0.67-0.49-0.71-0.34-0.35-0.741.0-0.741.00.04-0.740.990.040.990.050.96-0.06-0.31-0.26-0.44-0.48-0.410.42
-0.67-0.5-0.72-0.35-0.36-0.741.0-0.751.00.05-0.740.990.030.990.050.96-0.06-0.31-0.26-0.44-0.48-0.410.42
0.960.480.970.850.851.0-0.74-0.75-0.73-0.151.0-0.680.44-0.67-0.08-0.61-0.020.580.550.190.81-0.150.12
-0.66-0.49-0.7-0.33-0.34-0.731.01.0-0.730.04-0.730.990.050.990.050.96-0.07-0.3-0.25-0.45-0.47-0.420.43
-0.21-0.2-0.22-0.16-0.15-0.170.040.05-0.150.04-0.160.0-0.40.01-0.090.1-0.11-0.23-0.3-0.02-0.540.26-0.27
0.960.460.990.850.861.0-0.74-0.741.0-0.73-0.16-0.680.44-0.67-0.07-0.61-0.010.580.550.160.82-0.160.14
-0.61-0.44-0.65-0.27-0.28-0.670.990.99-0.680.990.0-0.680.140.990.110.96-0.02-0.2-0.15-0.41-0.42-0.490.5
0.490.590.440.530.520.450.040.030.440.05-0.40.440.140.120.130.110.060.690.71-0.050.64-0.780.78
-0.59-0.43-0.64-0.25-0.26-0.660.990.99-0.670.990.01-0.670.990.12-0.060.98-0.18-0.28-0.23-0.48-0.38-0.450.46
-0.17-0.1-0.07-0.14-0.14-0.070.050.05-0.080.05-0.09-0.070.110.13-0.06-0.070.980.490.50.38-0.27-0.260.26
-0.53-0.4-0.61-0.19-0.2-0.610.960.96-0.610.960.1-0.610.960.110.98-0.07-0.2-0.23-0.19-0.41-0.38-0.440.45
-0.12-0.120.0-0.13-0.13-0.01-0.06-0.06-0.02-0.07-0.11-0.01-0.020.06-0.180.98-0.20.440.450.36-0.22-0.180.18
0.530.590.550.590.590.58-0.31-0.310.58-0.3-0.230.58-0.20.69-0.280.49-0.230.440.990.520.4-0.350.52
0.490.580.510.580.580.55-0.26-0.260.55-0.25-0.30.55-0.150.71-0.230.5-0.190.450.990.520.41-0.370.53
0.010.490.05-0.06-0.060.16-0.44-0.440.19-0.45-0.020.16-0.41-0.05-0.480.38-0.410.360.520.52-0.120.37-0.38
0.880.490.840.740.750.83-0.48-0.480.81-0.47-0.540.82-0.420.64-0.38-0.27-0.38-0.220.40.41-0.12-0.380.32
-0.22-0.08-0.19-0.31-0.3-0.16-0.41-0.41-0.15-0.420.26-0.16-0.49-0.78-0.45-0.26-0.44-0.18-0.35-0.370.37-0.38-0.8
0.240.090.20.470.450.150.420.420.120.43-0.270.140.50.780.460.260.450.180.520.53-0.380.32-0.8
Click cells to compare fundamentals

CytomX Therapeutics Account Relationship Matchups

CytomX Therapeutics income statement Accounts

201920202021202220232024 (projected)
Interest Expense10.8M1.8M172K2.0M2.3M2.1M
Total Revenue57.5M100.4M69.6M53.2M101.2M54.2M
Gross Profit57.5M100.4M69.6M53.2M99.0M53.9M
Operating Income(110.9M)(48.6M)(83.8M)(101.3M)(6.5M)(6.8M)
Ebit(110.9M)(48.6M)(83.8M)(101.3M)(6.5M)(6.8M)
Research Development131.6M112.9M114.2M111.6M75.7M86.4M
Ebitda(108.3M)(46.0M)(81.1M)(98.9M)(4.3M)(4.5M)
Cost Of Revenue105.5M0.05.8M5.9M2.2M2.1M
Income Before Tax(102.7M)(46.8M)(83.6M)(99.3M)3.3M3.5M
Net Income(102.2M)(32.9M)(80.6M)(97.3M)(569K)(597.5K)
Income Tax Expense(427K)(13.9M)(3.0M)(2.0M)3.9M4.1M
Tax Provision14.3M(427K)(13.9M)0.02.8M3.0M
Interest Income8.4M1.8M255K1.7M8.1M4.1M
Net Interest Income8.4M1.8M255K1.7M8.1M4.3M

Pair Trading with CytomX Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CytomX Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with CytomX Stock

  0.67MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.61EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against CytomX Stock

  0.85KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.61MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.57VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.52MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to CytomX Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CytomX Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CytomX Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CytomX Therapeutics to buy it.
The correlation of CytomX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CytomX Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CytomX Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CytomX Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CytomX Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytomX Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomx Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomx Therapeutics Stock:
Check out CytomX Therapeutics Valuation and CytomX Therapeutics Correlation analysis.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for CytomX Stock analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is CytomX Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytomX Therapeutics. If investors know CytomX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytomX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.322
Return On Assets
(0.02)
Return On Equity
(54.75)
The market value of CytomX Therapeutics is measured differently than its book value, which is the value of CytomX that is recorded on the company's balance sheet. Investors also form their own opinion of CytomX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytomX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytomX Therapeutics' market value can be influenced by many factors that don't directly affect CytomX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytomX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytomX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytomX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.